Lucid Scientific Highlighted by Memorial Sloan Kettering Cancer Center in The Scientist

In this latest issue of The Scientist, portfolio company Lucid Scientific's Recipher Platform is highlighted by researchers at Memorial Sloan Kettering Cancer Center as a novel way to measure live oxygen consumption rate (OCR) in cell culture. OCR, and more specifically the amount of oxygen available at the cells is a critical parameter Lucid's technology provides.